Medtronic eyes backing Japan startups as Trump deals bring 'clarity'

World's top medical device maker adjusts supply chain to limit tariff burden

20250730 Medtronic interview

Geoff Martha, CEO of Medtronic, said the company is working to reduce the impact of U.S. tariffs. (Nikkei montage/Source photos by Manami Yamada and Reuters) 

YUTA MAEDA and MITSURU OBE

TOKYO -- Medtronic, the world's largest medical device maker, is considering investment in Japanese startups in areas such as artificial intelligence, citing improved "clarity" on the global economic outlook following a series of tariff deals between the U.S. and other countries.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.